Skip to content
Screener

Prestige Consumer Healthcare PBH Q4 2025 Annual earnings

Reported May 8, 2025 · Before market open

Revenue$296.8MBeat by $26.3M
EPS$1.32Beat by $0.02
Revenue estimate$270.4M
EPS estimate$1.30

Next report

Nov 5, 2026 (in 2 months)
Revenue estimate$329.1M
EPS estimate$1.06

Financials

Q4 2025

Income statement

See full
Revenue$296.5M+7.0%
Gross profit$170.0M+12.0%
Operating income$88.4M+7.6%
Net income$50.1M+1.4%
EPS (diluted)$1.01+3.1%

Balance sheet

See full
Cash & equivalents$97.9M+111%
Total debt$1.0B-9.0%
Total equity$1.8B+10.9%
Total assets$3.4B+2.5%

Cash flow

See full
Operating cash flow$61.8M-7.6%
CapEx$3.5M+10.7%
Free cash flow$58.4M-8.5%

Valuation & ratios

Valuation

as of 03/31/25
See full
Market cap$4.26B+18.0%
Enterprise value$5.21B+10.5%
P/E19.8×+2.6×
P/S3.7×+0.5×

Profitability

See full
Gross margin55.8%+0.3pp
Operating margin29.6%-0.8pp
Net margin18.9%+0.3pp
FCF margin21.4%+0.1pp

Returns & leverage

See full
Return on equity12.3%-1.2pp
Debt / equity0.6×-0.1×
Current ratio4.2×+1.0×

Segments

By product

See full
Gastrointestinal$68.9M+15.5%
Women's Health$63.8M+6.0%
Eye & Ear Care$46.7M+6.2%
Dermatologicals$29.1M-5.7%
Oral Care$27.1M+7.0%

By segment

See full
North American OTC Healthcare$248.9M+7.7%
International OTC Healthcare$47.6M+3.7%

FAQ

When did Prestige Consumer Healthcare report Q4 2025 earnings?
Prestige Consumer Healthcare (PBH) reported Q4 2025 earnings on May 8, 2025 before market open.
What were Prestige Consumer Healthcare's Q4 2025 revenue and EPS?
Prestige Consumer Healthcare reported revenue of $296.8M and eps of $1.32 for Q4 2025.
Did Prestige Consumer Healthcare beat estimates in Q4 2025?
Revenue beat the consensus estimate of $270.4M by $26.3M. EPS beat the consensus estimate of $1.30 by $0.02.
How did Prestige Consumer Healthcare's Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 7.1% from $277.0M a year earlier and eps grew 34.7% from $0.98.
Where can I find Prestige Consumer Healthcare's Q4 2025 SEC filings?
You can read the 8-K earnings release (0001295947-25-000014) and the 10-K periodic report (0001295947-25-000017) directly on SEC EDGAR. The filing index links above go to sec.gov.